Me. Alburges et al., ALPHA(2)-AGONIST BINDING-SITES IN BRAIN - [I-125] PARA-IODOCLONIDINE VERSUS [H-3] PARA-AMINOCLONIDINE, Brain research bulletin, 32(2), 1993, pp. 97-102
The localization of alpha2-receptors was determined by quantitative au
toradiography using [I-125]para-iodoclonidine ([I-125]PIC) and [H-3]pa
ra-aminoclonidine ([H-3]PAC). In cortical tissue, [I-125]PIC and [H-3]
PAC were equipotent in their capacity to bind sites recognized by oxym
etazoline (preferentially binds to the alpha2A receptor subtype). The
iodinated ligand was about 10 times more potent than [H-3]PAC for bind
ing to the heterogenous receptor population labeled by ARC-239 (alpha2
B and alpha2C). The density of [I-125]PIC binding was found to be two-
fold higher than that of [H-3]PAC in many brain areas and the disparit
y was even greater in regions such as the dentate gyrus, stria termina
lis, and granular layer of the cerebellum. By contrast, other regions
of the brain such as the laterodorsal thalamic nucleus, the locus coer
uleus, and several amygdaloid areas had equivalent levels of binding.
These observations indicate that [H-3]PAC has selectivity for the alph
a2A receptor subtype and thus offer a restricted view of alpha2-adrene
rgic receptor distribution. The iodinated ligand provides a more compl
ete picture of the overall alpha2 receptor population.